PLRX
Price
$1.52
Change
+$0.08 (+5.56%)
Updated
Sep 26 closing price
Capitalization
93.31M
44 days until earnings call
RIGL
Price
$28.63
Change
-$0.07 (-0.24%)
Updated
Sep 26 closing price
Capitalization
513.55M
Interact to see
Advertisement

PLRX vs RIGL

Header iconPLRX vs RIGL Comparison
Open Charts PLRX vs RIGLBanner chart's image
Pliant Therapeutics
Price$1.52
Change+$0.08 (+5.56%)
Volume$369.13K
Capitalization93.31M
Rigel Pharmaceuticals
Price$28.63
Change-$0.07 (-0.24%)
Volume$697.44K
Capitalization513.55M
PLRX vs RIGL Comparison Chart in %
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. RIGL commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Buy and RIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (PLRX: $1.52 vs. RIGL: $28.63)
Brand notoriety: PLRX and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 45% vs. RIGL: 93%
Market capitalization -- PLRX: $93.31M vs. RIGL: $513.55M
PLRX [@Biotechnology] is valued at $93.31M. RIGL’s [@Biotechnology] market capitalization is $513.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 1 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, RIGL is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 2 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 2 bullish, 7 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а +6.29% price change this week, while RIGL (@Biotechnology) price change was -17.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($514M) has a higher market cap than PLRX($93.3M). RIGL YTD gains are higher at: 70.214 vs. PLRX (-88.459). RIGL has higher annual earnings (EBITDA): 109M vs. PLRX (-201.76M). PLRX has more cash in the bank: 263M vs. RIGL (108M). PLRX (60.4M) and RIGL (61M) have identical debt. RIGL has higher revenues than PLRX: RIGL (268M) vs PLRX (0).
PLRXRIGLPLRX / RIGL
Capitalization93.3M514M18%
EBITDA-201.76M109M-185%
Gain YTD-88.45970.214-126%
P/E RatioN/A5.27-
Revenue0268M-
Total Cash263M108M244%
Total Debt60.4M61M99%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
8
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXRIGL
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 26 days ago
77%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGELX94.500.91
+0.97%
Vanguard Energy Adm
VYSYX11.260.09
+0.81%
Voya Small Company A
VKSFX10.260.08
+0.79%
Virtus KAR Small-Mid Cap Value I
IDHCX20.220.15
+0.75%
Integrity Dividend Harvest C
NWKCX80.330.51
+0.64%
Nationwide Geneva Small Cap Gr R6

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with OCUL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+5.56%
OCUL - PLRX
43%
Loosely correlated
+2.37%
SRRK - PLRX
40%
Loosely correlated
+12.35%
LXRX - PLRX
39%
Loosely correlated
+4.48%
RIGL - PLRX
38%
Loosely correlated
-0.24%
SLDB - PLRX
37%
Loosely correlated
+3.89%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-0.24%
CLNN - RIGL
92%
Closely correlated
+0.09%
PHIO - RIGL
84%
Closely correlated
+1.36%
AZTR - RIGL
84%
Closely correlated
-2.48%
IMRN - RIGL
82%
Closely correlated
+0.26%
CELZ - RIGL
39%
Loosely correlated
+1.69%
More